Form 4 for IONQ IonQ, Inc.
Accepted 2023-08-17 00:00:00 ET · period of report 2023-08-15 · accession 0001209191-23-046384 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-17 | 2023-08-15 | IONQ | Monroe Christopher | Chief Scientist | A - Grant | $0.00 | +41.7K | 3.90M | +1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-15 | A | A | 41,716 | $0.00 | 3,897,970 | D | — | — | (F1) Represents a restricted stock unit ("RSU") award. The RSUs shall vest 1/16th of the total number of shares underlying the awards on September 10, 2023 and quarterly thereafter on each subsequent December 10, March 10, June 10 and September 10, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. |